Wall Street Remains Positive on Walgreens
Can Walgreens Exceed Analyst Expectations for Fiscal Q3 2018? The company is rated a 2.3 on a scale where one is a “strong buy” and five is a “strong sell.” It was rated a 2.0 at the end of June 2017. In comparison, CVS Health has a slightly better rating of 2.0, while Rite Aid (RAD) has a rating of 3.0.